[Pyr1]-Apelin-13

[Pyr1]-Apelin-13 is an inhibitor of GPR used in studies of GPCR Signaling. It is especially relevant in cardiovascular and cell signaling models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

By inhibiting GPR, [Pyr1]-Apelin-13 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cardiovascular and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving GPR
• Pathway perturbation studies connected to GPCR Signaling
• Concentration-response inhibition and target-dependence studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, [Pyr1]-Apelin-13 is appropriate when a defined chemical perturbant is needed to connect GPR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.